Gel Increases Success Rate of AVF Development
Researchers at the University of Alabama at Birmingham and Endomimetics, a biotechnology company, have showed that a self-assembling, nanomatrix gel that releases nitric oxide helped create a fully developed arteriovenous fistula (AVF) in rodents. The gel helps prevent overgrowth of cells at the anastomosis.
Read the full article » | Posted 01-14-2022
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025

